Request Demo
Last update 08 Feb 2025
Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)
Last update 08 Feb 2025
Overview
Basic Info
Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Pegfilgrastim (Shandong Kexing Bioproducts), 升白针, 聚乙二醇化人粒细胞刺激因子（科兴生物制药） + [1] |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4190
The sequence is quoted from: *****
Related
6
Clinical Trials associated with Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)CTR20244457
聚乙二醇化人粒细胞刺激因子注射液（PEG-G-CSF）预防化疗后中性粒细胞减少的有效性和安全性的Ⅲ期临床研究
[Translation] Phase III clinical study on the efficacy and safety of PEG-G-CSF in preventing neutropenia after chemotherapy
NCT06711523
A Phase III Clinical Study of the Efficacy and Safety of Polyethylene Glycolized Human Granulocyte Stimulating Factor Injection (PEG-G-CSF) in Preventing Neutropenia After Chemotherapy
CTR20230867
国产PEG-G-CSF注射液与原研PEG-G-CSF注射液(Neulasta®)在健康受试者中对比药代动力学、药效动力学、安全性和免疫原性的生物等效性研究。
[Translation] A bioequivalence study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of domestically produced PEG-G-CSF injection with that of the original PEG-G-CSF injection (Neulasta®) in healthy subjects.
100 Clinical Results associated with Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)
Login to view more data
100 Translational Medicine associated with Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)
Login to view more data
100 Patents (Medical) associated with Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)
Login to view more data
100 Deals associated with Pegylated human granulocyte colony stimulating factor(Shandong Kexing Bioproducts)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 3 | CN | 31 Dec 2024 | |
| Chemotherapy-Induced Febrile Neutropenia | Phase 3 | CN | 31 Dec 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 70 | PEG-rhG-CSF+rhG-CSF (AOB) | wrwyqveoau(jzucvcxwyc) = atprbdegmo sktnrdmdtd (dmfknsxmjj ) View more | Positive | 31 May 2023 | ||
rhG-CSF+PEG-rhG-CSF (BOA) | wrwyqveoau(jzucvcxwyc) = ownmwadwyk sktnrdmdtd (dmfknsxmjj ) View more | ||||||
Not Applicable | 103 | uqvcnbziby(vqjnhrwwok) = qocncljisi vfzownpxbb (sbxuxwpzsb ) | Positive | 10 Jun 2022 | |||
Not Applicable | 60 | qiyvdlleoi(lftjimqhcb) = nesmmbakwn uwsbshrdys (iposixytdt, (17 - 49)) View more | - | 26 May 2019 | |||
rhG-CSF | qiyvdlleoi(lftjimqhcb) = wnlcsduonj uwsbshrdys (iposixytdt, (19 - 43)) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free